Field collections and environmental DNA surveys reveal topographic complexity of coral reefs as a predictor of cryptobenthic biodiversity across small spatial scales

Autor: O. B. Brodnicke, M. R. Jensen, P. F. Thomsen, T. Brorly, B. L. Andersen, S. W. Knudsen, K. Præbel, S. J. Brandl, M. J. Sweet, P. R. Møller, K. Worsaae

Publikováno v: Environmental DNA, Vol 6, Iss 3, Pp n/a-n/a (2024)

Abstract Coral reefs represent some of the most biodiverse ecosystems in the world but are currently undergoing large‐scale degradation due to anthropogenic stressors. Such degradation usually begins with coral bleaching, and if the stress conditio

Externí odkaz: https://doaj.org/article/81870658cca84152be4f54f34a44ccee

Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4):an observational nationwide study applying linkage between DANBIO and national registries

Autor: Stylianos Georgiadis, Kamilla Danebod, Jolanta Grydehøj, Merete Lund Hetland, Johnny Lillelund Raun, Stavros Chrysidis, Salome Kristensen, Charlotte Wiell, Bente Glintborg, Natalia Manilo, Anders Villumsen, Hanne Merete Lindegaard, Dorte Vendelbo Jensen, Frank Mehnert, Mette Nørgaard, Anne Gitte Loft, Niels Steen Krogh, Grith Eng, Oliver Hendricks, Asta Linauskas, B. L. Andersen

Publikováno v: Glintborg, B, Georgiadis, S, Loft, A G, Linauskas, A, Lindegaard, H, Hendricks, O, Jensen, D V, Andersen, B L, Danebod, K, Villumsen, A, Eng, G, Wiell, C, Manilo, N, Kristensen, S, Raun, J, Grydehøj, J, Chrysidis, S, Nørgaard, M, Mehnert, F, Krogh, N S & Hetland, M L 2020, ' Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4) : an observational nationwide study applying linkage between DANBIO and national registries ', Annals of the Rheumatic Diseases, vol. 79, no. 6, pp. 846-848 . https://doi.org/10.1136/annrheumdis-2019-216702
Glintborg, B, Georgiadis, S, Loft, A G R, Linauskas, A, Lindegaard, H, Hendricks, O, Jensen, D V, Lange Andersen, B, Danebod, K, Villumsen, A, Eng, G, Wiell, C, Manilo, N, Kristensen, S, Raun, J L, Grydehøj, J, Chrysidis, S, Nørgaard, M, Mehnert, F, Krogh, N S & Lund Hetland, M 2020, ' Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): an observational nationwide study applying linkage between DANBIO and national registries ', Annals of the Rheumatic Diseases, bind 79, nr. 6 . https://doi.org/10.1136/annrheumdis-2019-216702
Glintborg, B, Georgiadis, S, Loft, A G, Linauskas, A, Lindegaard, H, Hendricks, O, Jensen, D V, Andersen, B L, Danebod, K, Villumsen, A, Eng, G, Wiell, C, Manilo, N, Kristensen, S, Raun, J, Grydehøj, J, Chrysidis, S, Nørgaard, M, Mehnert, F, Krogh, N S & Hetland, M L 2020, ' Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4) : An observational nationwide study applying linkage between DANBIO and national registries ', Annals of the rheumatic diseases, vol. 79, no. 6, pp. 846-848 . https://doi.org/10.1136/annrheumdis-2019-216702

Recent international guidelines recommend the use of biosimilar biological drugs on similar terms as their corresponding originators, including switching from a bio-originator to the biosimilar.1 However, the comparative safety of biosimilars in pati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b67904a17aae6d2a100c9d8e44060c0e
https://vbn.aau.dk/da/publications/1af94544-8bca-444e-aa8a-980b51288dff

THU0189 One-year treatment retention after a nationwide non-medical switch from originator to biosimilar etanercept in 2,061 patients with inflammatory arthritis followed in the danbio registry

Autor: Dorte Dalsgaard Pedersen, Emina Omerovic, Kamilla Danebod, Johnny Lillelund Raun, L.S. Andersen, Dorte Vendelbo Jensen, Natalia Manilo, Merete Lund Hetland, Anne Gitte Loft, Niels Steen Krogh, Oliver Hendricks, Hanne Merete Lindegaard, Asta Linauskas, Henrik Nordin, Inger Marie Jensen Hansen, Jakob Espesen, Susanne Højmark Jakobsen, Salome Kristensen, Frank Mehnert, B. L. Andersen, Inge Juul Sørensen, E. B. Dalsgaard, Stavros Chrysidis, Bente Glintborg, Jolanta Grydehøj

Publikováno v: THURSDAY, 14 JUNE 2018.

Background In Denmark, rheumatoid arthritis(RA), psoriatic arthritis(PsA) and axial spondyloarthritis(AxSpA) patients (pts) treated with originator etanercept (ETA) 50 mg SC conducted a mandatory non-medical switch to biosimilar Etanercept (SB4) in A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9324aaf2ec8b0f9fbd6ac843fb9a02f6
https://doi.org/10.1136/annrheumdis-2018-eular.2113

Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study

Autor: Cato Mork, S. Kroon, Gregor B.E. Jemec, K. M. Brocks, Ida Marie Stender, Kristina S Ibler, Hans Christian Wulf, Susanne Fabricius, Carin Sandberg, Peter A. Philipsen, Monika Gniadecka, Merete Haedersdal, B. L. Andersen, Jakob Heydenreich, S.R. Wiegell, Berit Berne

Publikováno v: British Journal of Dermatology. 166:1327-1332

Summary Background Photodynamic therapy (PDT) is an attractive therapy for nonmelanoma skin cancers and actinic keratoses (AKs). Daylight-mediated PDT is a simple and tolerable treatment procedure for PDT. Methyl aminolaevulinate (MAL)-PDT is approve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0c3bcab4d9331088d48495b5c117aace
https://doi.org/10.1111/j.1365-2133.2012.10833.x

Nurse‐Led Screening‐Triggered Early Specialized Palliative Care Program for Patients With Advanced Lung Cancer: A Multicenter Randomized Controlled Trial.

Autor: Matsumoto, Yoshihisa^1,2 (AUTHOR) yoshihisa.matsumoto@jfcr.or.jp, Umemura, Shigeki³ (AUTHOR), Okizaki, Ayumi^1,4,5 (AUTHOR), Fujisawa, Daisuke⁶ (AUTHOR), Yamaguchi, Takuhiro⁷ (AUTHOR), Oyamada, Shunsuke^7,8 (AUTHOR), Miyaji, Tempei^5,9 (AUTHOR), Mashiko, Tomoe⁵ (AUTHOR), Kobayashi, Naoko¹⁰ (AUTHOR), Satomi, Eriko¹¹ (AUTHOR), Kiuchi, Daisuke^11,12 (AUTHOR), Morita, Tatsuya¹³ (AUTHOR), Uchitomi, Yosuke^4,5 (AUTHOR), Goto, Koichi³ (AUTHOR), Ohe, Yuichiro¹⁴ (AUTHOR)

Publikováno v: Cancer Medicine. Nov2024, Vol. 13 Issue 22, p1-11. 11p.